Cargando…
Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals
BACKGROUND: Colorectal high-grade neuroendocrine neoplasms (HGNENs) are rare and constitute less than 1% of all colorectal malignancies. Based on their morphological differentiation and proliferation identity, these neoplasms present heterogeneous clinicopathologic features. Opinions regarding treat...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747289/ https://www.ncbi.nlm.nih.gov/pubmed/31558867 http://dx.doi.org/10.3748/wjg.v25.i34.5197 |
_version_ | 1783451867724906496 |
---|---|
author | Wang, Zhi-Jie An, Ke Li, Rui Shen, Wei Bao, Man-Dula Tao, Jin-Hua Chen, Jia-Nan Mei, Shi-Wen Shen, Hai-Yu Ma, Yun-Bin Zhao, Fu-Qiang Wei, Fang-Ze Liu, Qian |
author_facet | Wang, Zhi-Jie An, Ke Li, Rui Shen, Wei Bao, Man-Dula Tao, Jin-Hua Chen, Jia-Nan Mei, Shi-Wen Shen, Hai-Yu Ma, Yun-Bin Zhao, Fu-Qiang Wei, Fang-Ze Liu, Qian |
author_sort | Wang, Zhi-Jie |
collection | PubMed |
description | BACKGROUND: Colorectal high-grade neuroendocrine neoplasms (HGNENs) are rare and constitute less than 1% of all colorectal malignancies. Based on their morphological differentiation and proliferation identity, these neoplasms present heterogeneous clinicopathologic features. Opinions regarding treatment strategies for and improvement of the clinical outcomes of these patients remain controversial. AIM: To delineate the clinicopathologic features of and explore the prognostic factors for this rare malignancy. METHODS: This observational study reviewed the data of 72 consecutive patients with colorectal HGNENs from three Chinese hospitals between 2000 and 2019. The clinicopathologic characteristics and follow-up data were carefully collected from their medical records, outpatient reexaminations, and telephone interviews. A survival analysis was conducted to evaluate their outcomes and to identify the prognostic factors for this disease. RESULTS: According to the latest recommendations for the classification and nomenclature of colorectal HGNENs, 61 (84.7%) patients in our cohort had poorly differentiated neoplasms, which were categorized as high-grade neuroendocrine carcinomas (HGNECs), and the remaining 11 (15.3%) patients had well differentiated neoplasms, which were categorized as high-grade neuroendocrine tumors (HGNETs). Most of the neoplasms (63.9%) were located at the rectum. More than half of the patients (51.4%) presented with distant metastasis at the date of diagnosis. All patients were followed for a median duration of 15.5 mo. In the entire cohort, the median survival time was 31 mo, and the 3-year and 5-year survival rates were 44.3% and 36.3%, respectively. Both the univariate and multivariate analyses demonstrated that increasing age, HGNEC type, and distant metastasis were risk factors for poor clinical outcomes. CONCLUSION: Colorectal HGNENs are rare and aggressive malignancies with poor clinical outcomes. However, patients with younger age, good morphological differentiation, and without metastatic disease can have a relatively favorable prognosis. |
format | Online Article Text |
id | pubmed-6747289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-67472892019-09-26 Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals Wang, Zhi-Jie An, Ke Li, Rui Shen, Wei Bao, Man-Dula Tao, Jin-Hua Chen, Jia-Nan Mei, Shi-Wen Shen, Hai-Yu Ma, Yun-Bin Zhao, Fu-Qiang Wei, Fang-Ze Liu, Qian World J Gastroenterol Observational Study BACKGROUND: Colorectal high-grade neuroendocrine neoplasms (HGNENs) are rare and constitute less than 1% of all colorectal malignancies. Based on their morphological differentiation and proliferation identity, these neoplasms present heterogeneous clinicopathologic features. Opinions regarding treatment strategies for and improvement of the clinical outcomes of these patients remain controversial. AIM: To delineate the clinicopathologic features of and explore the prognostic factors for this rare malignancy. METHODS: This observational study reviewed the data of 72 consecutive patients with colorectal HGNENs from three Chinese hospitals between 2000 and 2019. The clinicopathologic characteristics and follow-up data were carefully collected from their medical records, outpatient reexaminations, and telephone interviews. A survival analysis was conducted to evaluate their outcomes and to identify the prognostic factors for this disease. RESULTS: According to the latest recommendations for the classification and nomenclature of colorectal HGNENs, 61 (84.7%) patients in our cohort had poorly differentiated neoplasms, which were categorized as high-grade neuroendocrine carcinomas (HGNECs), and the remaining 11 (15.3%) patients had well differentiated neoplasms, which were categorized as high-grade neuroendocrine tumors (HGNETs). Most of the neoplasms (63.9%) were located at the rectum. More than half of the patients (51.4%) presented with distant metastasis at the date of diagnosis. All patients were followed for a median duration of 15.5 mo. In the entire cohort, the median survival time was 31 mo, and the 3-year and 5-year survival rates were 44.3% and 36.3%, respectively. Both the univariate and multivariate analyses demonstrated that increasing age, HGNEC type, and distant metastasis were risk factors for poor clinical outcomes. CONCLUSION: Colorectal HGNENs are rare and aggressive malignancies with poor clinical outcomes. However, patients with younger age, good morphological differentiation, and without metastatic disease can have a relatively favorable prognosis. Baishideng Publishing Group Inc 2019-09-14 2019-09-14 /pmc/articles/PMC6747289/ /pubmed/31558867 http://dx.doi.org/10.3748/wjg.v25.i34.5197 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Observational Study Wang, Zhi-Jie An, Ke Li, Rui Shen, Wei Bao, Man-Dula Tao, Jin-Hua Chen, Jia-Nan Mei, Shi-Wen Shen, Hai-Yu Ma, Yun-Bin Zhao, Fu-Qiang Wei, Fang-Ze Liu, Qian Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals |
title | Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals |
title_full | Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals |
title_fullStr | Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals |
title_full_unstemmed | Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals |
title_short | Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals |
title_sort | analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three chinese hospitals |
topic | Observational Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747289/ https://www.ncbi.nlm.nih.gov/pubmed/31558867 http://dx.doi.org/10.3748/wjg.v25.i34.5197 |
work_keys_str_mv | AT wangzhijie analysisof72patientswithcolorectalhighgradeneuroendocrineneoplasmsfromthreechinesehospitals AT anke analysisof72patientswithcolorectalhighgradeneuroendocrineneoplasmsfromthreechinesehospitals AT lirui analysisof72patientswithcolorectalhighgradeneuroendocrineneoplasmsfromthreechinesehospitals AT shenwei analysisof72patientswithcolorectalhighgradeneuroendocrineneoplasmsfromthreechinesehospitals AT baomandula analysisof72patientswithcolorectalhighgradeneuroendocrineneoplasmsfromthreechinesehospitals AT taojinhua analysisof72patientswithcolorectalhighgradeneuroendocrineneoplasmsfromthreechinesehospitals AT chenjianan analysisof72patientswithcolorectalhighgradeneuroendocrineneoplasmsfromthreechinesehospitals AT meishiwen analysisof72patientswithcolorectalhighgradeneuroendocrineneoplasmsfromthreechinesehospitals AT shenhaiyu analysisof72patientswithcolorectalhighgradeneuroendocrineneoplasmsfromthreechinesehospitals AT mayunbin analysisof72patientswithcolorectalhighgradeneuroendocrineneoplasmsfromthreechinesehospitals AT zhaofuqiang analysisof72patientswithcolorectalhighgradeneuroendocrineneoplasmsfromthreechinesehospitals AT weifangze analysisof72patientswithcolorectalhighgradeneuroendocrineneoplasmsfromthreechinesehospitals AT liuqian analysisof72patientswithcolorectalhighgradeneuroendocrineneoplasmsfromthreechinesehospitals |